Cargando…

Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study

OBJECTIVES: To compare WB-MRI with an [(18)F]FDG-PET/CT-based reference for early response assessment and restaging in children with Hodgkin’s lymphoma (HL). METHODS: Fifty-one children (ages 10–17) with HL were included in this prospective, multicentre study. All participants underwent WB-MRI and [...

Descripción completa

Detalles Bibliográficos
Autores principales: Spijkers, Suzanne, Littooij, Annemieke S., Kwee, Thomas C., Tolboom, Nelleke, Beishuizen, Auke, Bruin, Marrie C. A., Enríquez, Goya, Sábado, Constantino, Miller, Elka, Granata, Claudio, de Lange, Charlotte, Verzegnassi, Federico, de Keizer, Bart, Nievelstein, Rutger A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589741/
https://www.ncbi.nlm.nih.gov/pubmed/34021390
http://dx.doi.org/10.1007/s00330-021-08026-1
_version_ 1784598796183797760
author Spijkers, Suzanne
Littooij, Annemieke S.
Kwee, Thomas C.
Tolboom, Nelleke
Beishuizen, Auke
Bruin, Marrie C. A.
Enríquez, Goya
Sábado, Constantino
Miller, Elka
Granata, Claudio
de Lange, Charlotte
Verzegnassi, Federico
de Keizer, Bart
Nievelstein, Rutger A. J.
author_facet Spijkers, Suzanne
Littooij, Annemieke S.
Kwee, Thomas C.
Tolboom, Nelleke
Beishuizen, Auke
Bruin, Marrie C. A.
Enríquez, Goya
Sábado, Constantino
Miller, Elka
Granata, Claudio
de Lange, Charlotte
Verzegnassi, Federico
de Keizer, Bart
Nievelstein, Rutger A. J.
author_sort Spijkers, Suzanne
collection PubMed
description OBJECTIVES: To compare WB-MRI with an [(18)F]FDG-PET/CT-based reference for early response assessment and restaging in children with Hodgkin’s lymphoma (HL). METHODS: Fifty-one children (ages 10–17) with HL were included in this prospective, multicentre study. All participants underwent WB-MRI and [(18)F]FDG-PET/CT at early response assessment. Thirteen of the 51 patients also underwent both WB-MRI and [(18)F]FDG-PET/CT at restaging. Two radiologists independently evaluated all WB-MR images in two separate readings: without and with DWI. The [(18)F]FDG-PET/CT examinations were evaluated by a nuclear medicine physician. An expert panel assessed all discrepancies between WB-MRI and [(18)F]FDG-PET/CT to derive the [(18)F]FDG-PET/CT-based reference standard. Inter-observer agreement for WB-MRI was calculated using kappa statistics. Concordance, PPV, NPV, sensitivity and specificity for a correct assessment of the response between WB-MRI and the reference standard were calculated for both nodal and extra-nodal disease presence and total response evaluation. RESULTS: Inter-observer agreement of WB-MRI including DWI between both readers was moderate (κ 0.46–0.60). For early response assessment, WB-MRI DWI agreed with the reference standard in 33/51 patients (65%, 95% CI 51–77%) versus 15/51 (29%, 95% CI 19–43%) for WB-MRI without DWI. For restaging, WB-MRI including DWI agreed with the reference standard in 9/13 patients (69%, 95% CI 42–87%) versus 5/13 patients (38%, 95% CI 18–64%) for WB-MRI without DWI. CONCLUSIONS: The addition of DWI to the WB-MRI protocol in early response assessment and restaging of paediatric HL improved agreement with the [(18)F]FDG-PET/CT-based reference standard. However, WB-MRI remained discordant in 30% of the patients compared to standard imaging for assessing residual disease presence. KEY POINTS: • Inter-observer agreement of WB-MRI including DWI between both readers was moderate for (early) response assessment of paediatric Hodgkin’s lymphoma. • The addition of DWI to the WB-MRI protocol in early response assessment and restaging of paediatric Hodgkin’s lymphoma improved agreement with the [18F]FDG-PET/CT-based reference standard. • WB-MRI including DWI agreed with the reference standard in respectively 65% and 69% of the patients for early response assessment and restaging. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08026-1.
format Online
Article
Text
id pubmed-8589741
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85897412021-11-15 Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study Spijkers, Suzanne Littooij, Annemieke S. Kwee, Thomas C. Tolboom, Nelleke Beishuizen, Auke Bruin, Marrie C. A. Enríquez, Goya Sábado, Constantino Miller, Elka Granata, Claudio de Lange, Charlotte Verzegnassi, Federico de Keizer, Bart Nievelstein, Rutger A. J. Eur Radiol Paediatric OBJECTIVES: To compare WB-MRI with an [(18)F]FDG-PET/CT-based reference for early response assessment and restaging in children with Hodgkin’s lymphoma (HL). METHODS: Fifty-one children (ages 10–17) with HL were included in this prospective, multicentre study. All participants underwent WB-MRI and [(18)F]FDG-PET/CT at early response assessment. Thirteen of the 51 patients also underwent both WB-MRI and [(18)F]FDG-PET/CT at restaging. Two radiologists independently evaluated all WB-MR images in two separate readings: without and with DWI. The [(18)F]FDG-PET/CT examinations were evaluated by a nuclear medicine physician. An expert panel assessed all discrepancies between WB-MRI and [(18)F]FDG-PET/CT to derive the [(18)F]FDG-PET/CT-based reference standard. Inter-observer agreement for WB-MRI was calculated using kappa statistics. Concordance, PPV, NPV, sensitivity and specificity for a correct assessment of the response between WB-MRI and the reference standard were calculated for both nodal and extra-nodal disease presence and total response evaluation. RESULTS: Inter-observer agreement of WB-MRI including DWI between both readers was moderate (κ 0.46–0.60). For early response assessment, WB-MRI DWI agreed with the reference standard in 33/51 patients (65%, 95% CI 51–77%) versus 15/51 (29%, 95% CI 19–43%) for WB-MRI without DWI. For restaging, WB-MRI including DWI agreed with the reference standard in 9/13 patients (69%, 95% CI 42–87%) versus 5/13 patients (38%, 95% CI 18–64%) for WB-MRI without DWI. CONCLUSIONS: The addition of DWI to the WB-MRI protocol in early response assessment and restaging of paediatric HL improved agreement with the [(18)F]FDG-PET/CT-based reference standard. However, WB-MRI remained discordant in 30% of the patients compared to standard imaging for assessing residual disease presence. KEY POINTS: • Inter-observer agreement of WB-MRI including DWI between both readers was moderate for (early) response assessment of paediatric Hodgkin’s lymphoma. • The addition of DWI to the WB-MRI protocol in early response assessment and restaging of paediatric Hodgkin’s lymphoma improved agreement with the [18F]FDG-PET/CT-based reference standard. • WB-MRI including DWI agreed with the reference standard in respectively 65% and 69% of the patients for early response assessment and restaging. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08026-1. Springer Berlin Heidelberg 2021-05-22 2021 /pmc/articles/PMC8589741/ /pubmed/34021390 http://dx.doi.org/10.1007/s00330-021-08026-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Paediatric
Spijkers, Suzanne
Littooij, Annemieke S.
Kwee, Thomas C.
Tolboom, Nelleke
Beishuizen, Auke
Bruin, Marrie C. A.
Enríquez, Goya
Sábado, Constantino
Miller, Elka
Granata, Claudio
de Lange, Charlotte
Verzegnassi, Federico
de Keizer, Bart
Nievelstein, Rutger A. J.
Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study
title Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study
title_full Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study
title_fullStr Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study
title_full_unstemmed Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study
title_short Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study
title_sort whole-body mri versus an [(18)f]fdg-pet/ct-based reference standard for early response assessment and restaging of paediatric hodgkin’s lymphoma: a prospective multicentre study
topic Paediatric
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589741/
https://www.ncbi.nlm.nih.gov/pubmed/34021390
http://dx.doi.org/10.1007/s00330-021-08026-1
work_keys_str_mv AT spijkerssuzanne wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT littooijannemiekes wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT kweethomasc wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT tolboomnelleke wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT beishuizenauke wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT bruinmarrieca wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT enriquezgoya wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT sabadoconstantino wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT millerelka wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT granataclaudio wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT delangecharlotte wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT verzegnassifederico wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT dekeizerbart wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy
AT nievelsteinrutgeraj wholebodymriversusan18ffdgpetctbasedreferencestandardforearlyresponseassessmentandrestagingofpaediatrichodgkinslymphomaaprospectivemulticentrestudy